Understanding how cancer cells use water pressure to move through the body
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-May-2026 18:15 ET (30-May-2026 22:15 GMT/UTC)
Cancer cells often invade different tissues by forming rounded protrusions called blebs. However, the exact mechanism behind this expansion remained unclear. Now, researchers at Kyushu University have discovered that cancer cells use protein clusters to create water pressure inside blebs, which pushes the cell membrane outward, enabling rapid movement. This newly identified mechanism, named “CaMKII-based osmotically-driven deformation or CODE,” reveals a unique physical process that drives the spread of cancer cells inside the body.
A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other therapies directly to tumors, killing cancer cells without generating an immune response or toxicity-related side effects.
Outbreaks of avian flu at U.S. poultry farms led to more than $1.5 billion in losses over the last two years and drove egg prices to all-time highs in 2025.
A new program from the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service is investing $100 million in projects aimed at combating highly pathogenic avian influenza. As part of this national effort, Binghamton University has been awarded $2.5 million to develop a next-generation avian flu vaccine designed to be easier to manufacture, store and transport than current options.
The key ingredient is yeast — something that most of us have in our kitchens and consume daily.
Professor Sha Jin, a faculty member at the Thomas J. Watson College of Engineering and Applied Science’s Department of Biomedical Engineering, will spearhead the research project. Penn State University — which has the required biohazard containment facilities and testing facilities — will feed the altered yeast to chickens and then expose them to avian flu to evaluate immune protection.
The research team will bioengineer yeast cells to display the same hemagglutinin (HA) protein found on three H5N1 strains of the avian flu. When chickens ingest the yeast, it is expected to stimulate an immune response that prepares chickens to fight off future exposure to the live flu virus.
“We chose yeast because it’s edible and therefore safe,” Jin said. “In addition, yeast is already widely used in chickens because it can boost the health and immunity of the birds.”
In parts of Europe and Asia, chickens are inoculated with the inactivated flu viruses as part of their vaccination strategies. U.S. regulations do not allow that approach, because it is difficult to distinguish vaccinated birds from infected ones.
Using yeast also has other advantages: It is inexpensive to manufacture, shelf-stable at room temperature, does not require specialized equipment for administration and can be updated quickly when new viral strains emerge.
“For mRNA vaccines, refrigeration during transportation, handling and storage is essential to preserve biological activity,” Jin said. “Yeast can be handled and stored at room temperature, so it’s a lot easier for poultry farms to manage.”
The project is funded for three years, with the possibility of a one-year, no-cost extension if early results are promising and the team needs more time.
She emphasized the broader impact of the work: “A feedable yeast vaccine could prevent or halt avian influenza outbreaks, strengthen national food and biosecurity, reduce spillover risks to dairy cattle and humans, and ultimately save lives.”
About Binghamton University
Binghamton University, State University of New York, is the #1 public university in New York and a top-100 institution nationally. Founded in 1946, Binghamton combines a liberal arts foundation with professional and graduate programs, offering more than 130 academic undergraduate majors, minors, certificates, concentrations, emphases, tracks and specializations, plus more than 90 master's, 40 doctoral and 50 graduate certificate programs. The University is home to nearly 18,000 students and more than 150,000 alumni worldwide. Binghamton's commitment to academic excellence, innovative research, and student success has earned it recognition as a Public Ivy and one of the best values in American higher education.
In the first real-world study of lecanemab conducted in China, researchers found that lecanemab shows favorable safety and early effectiveness in Chinese patients with mild cognitive impairment and mild Alzheimer’s disease. Key findings include a lower incidence of adverse reactions, notably amyloid-related imaging abnormalities, cognitive stability after 6 months, increased plasma Aβ42 and Aβ40, and reduced amyloid plaques in the brain, though high dropout rates and absence of a control group warrant cautious interpretation.
Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs. Metastasis is the leading cause of cancer-related deaths and scientists are investigating ways to prevent it. These findings highlight new possibilities for developing clinical interventions to treat metastatic TNBC patients for whom there are no specific therapies.